Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 333

    1.

    Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.

    Howell SJ, Anderson E, Hunter T, Farnie G, Clarke RB.

    Breast Cancer Res. 2008;10(4):R68. Epub 2008 Aug 5.

    PMID:
    18681966
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Death receptor-dependent and -independent pathways in anticancer drug-induced apoptosis of breast cancer cells.

    Kim R, Tanabe K, Emi M, Uchida Y, Toge T.

    Oncol Rep. 2003 Nov-Dec;10(6):1925-30.

    PMID:
    14534720
    [PubMed - indexed for MEDLINE]
    3.

    Growth factors and chemotherapeutic modulation of breast cancer cells.

    Ciftci K, Su J, Trovitch PB.

    J Pharm Pharmacol. 2003 Aug;55(8):1135-41.

    PMID:
    12956904
    [PubMed - indexed for MEDLINE]
    4.

    Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.

    Costantini DL, Villani DF, Vallis KA, Reilly RM.

    J Nucl Med. 2010 Mar;51(3):477-83. Epub 2010 Feb 11.

    PMID:
    20150272
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.

    Konecny G, Untch M, Slamon D, Beryt M, Kahlert S, Felber M, Langer E, Lude S, Hepp H, Pegram M.

    Breast Cancer Res Treat. 2001 Jun;67(3):223-33.

    PMID:
    11561768
    [PubMed - indexed for MEDLINE]
    6.

    Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.

    Gewirtz DA, Di X, Walker TD, Sawyer ST.

    Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2232-8.

    PMID:
    16609039
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity.

    Redondo M, Téllez T, Roldan MJ, Serrano A, García-Aranda M, Gleave ME, Hortas ML, Morell M.

    Breast Cancer Res. 2007;9(6):R86.

    PMID:
    18078515
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.

    Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R.

    Cancer Res. 2000 Apr 1;60(7):2040-8.

    PMID:
    10766196
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15.

    Ballaré C, Portela P, Schiaffi J, Yomha R, Mordoh J.

    Breast Cancer Res Treat. 1998 Jan;47(2):163-70.

    PMID:
    9497104
    [PubMed - indexed for MEDLINE]
    10.

    Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.

    Beck MT, Chen NY, Franek KJ, Chen WY.

    Cancer Res. 2003 Jul 1;63(13):3598-604.

    PMID:
    12839947
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.

    Koutsilieris M, Reyes-Moreno C, Choki I, Sourla A, Doillon C, Pavlidis N.

    Mol Med. 1999 Feb;5(2):86-97.

    PMID:
    10203574
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.

    Shi P, Wang MM, Jiang LY, Liu HT, Sun JZ.

    Chin Med J (Engl). 2008 Oct 20;121(20):1975-9.

    PMID:
    19080259
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Expression of sigma 1 receptor in human breast cancer.

    Wang B, Rouzier R, Albarracin CT, Sahin A, Wagner P, Yang Y, Smith TL, Meric-Bernstam F, Marcelo Aldaz C, Hortobagyi GN, Pusztai L.

    Breast Cancer Res Treat. 2004 Oct;87(3):205-14. Erratum in: Breast Cancer Res Treat. 2005 Jan;89(1):95. Marcelo, AC [corrected to Marcelo Aldaz, C].

    PMID:
    15528963
    [PubMed - indexed for MEDLINE]
    14.

    Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.

    Gong SJ, Jin CJ, Rha SY, Chung HC.

    Cancer Lett. 2004 Oct 28;214(2):215-24.

    PMID:
    15363548
    [PubMed - indexed for MEDLINE]
    15.

    Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.

    Fuh G, Wells JA.

    J Biol Chem. 1995 Jun 2;270(22):13133-7.

    PMID:
    7768908
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.

    Hahm HA, Dunn VR, Butash KA, Deveraux WL, Woster PM, Casero RA Jr, Davidson NE.

    Clin Cancer Res. 2001 Feb;7(2):391-9.

    PMID:
    11234895
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R.

    Beck MT, Peirce SK, Chen WY.

    Oncogene. 2002 Aug 1;21(33):5047-55.

    PMID:
    12140755
    [PubMed - indexed for MEDLINE]
    Free Article
    18.

    The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.

    Wang Z, Butt K, Wang L, Liu H.

    Nutr Cancer. 2007;58(2):230-8.

    PMID:
    17640170
    [PubMed - indexed for MEDLINE]
    19.

    Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.

    LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassi el M, Afton SE, Ben-Jonathan N.

    Carcinogenesis. 2009 Aug;30(8):1298-304. Epub 2009 May 14.

    PMID:
    19443905
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

    Peirce SK, Chen WY, Chen WY.

    J Endocrinol. 2001 Oct;171(1):R1-4.

    PMID:
    11572805
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk